Disparities Among Liver Transplant Patients
- Conditions
- End Stage Liver DIsease
- Registration Number
- NCT05981196
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
- Detailed Description
Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction.
Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender).
Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Patients with end-stage liver, kidney, or cardiac dysfunction.
- Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.
- Patients with potential medical exclusions for transplant.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Organ transplantation Approximately one year Number of subject to receive an organ transplantation
Liver transplant waiting list Approximately one year Number of subjects listed on the liver transplant waiting list
- Secondary Outcome Measures
Name Time Method Survival Approximately one year post-transplant, or until you are removed from the transplant list Total number of subject alive
Graft survival at one year One year post transplant Total number of subject to have a functioning graft at one year post transplant
Graft survival at six months Six months post transplant Total number of subject to have a functioning graft at six months post transplant
Trial Locations
- Locations (1)
Mayo Clinic Arizona
🇺🇸Phoenix, Arizona, United States